Paul Foulger

Elsevier Ltd. engages in the provision of information analytics solutions. It offers digital solutions and tools in the areas of strategic research management, research and development performance, clinical decision support, and professional education, including ScienceDirect, Scopus, SciVal, ClinicalKey, Mendeley, Knovel, Reaxys, Evolve, and Sherpath. The company was founded in 1880 and is headquartered in Oxford, the United Kingdom.

Curidium Medica Ltd. engaged in the development targeted medicines and companion diagnostics used in the medical sector. The company was founded on July 25, 2003 and was headquartered in Wetherby, the United Kingdom.

Sec Newgate UK Ltd. is a holding company, which engages in the provision of communications and marketing services through subsidiaries. It operates through the following segments: Corporate Communications, Marketing and Advertising, and Head Office. The Corporate Communications segment provides public relations, public affairs, and corporate communication services. The Marketing and Advertising segment offers media buying, creative advertising, marketing, and corporate branding services. The Head Office segment consist of group treasury and finance and management services. The company was founded on February 4, 2005 and is headquartered in London, the United Kingdom.

Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland.

Arcis Biotechnology Ltd. develops and researches surface protection technology. It is an R&D company developing new technologies for durable antimicrobial applications across multiple sectors. The firm develops a surface protection technology that is designed to kill a spectrum of micro-organisms, including bacteria, virus, germinating spores, fungi, mould, algae, and moss. The company was founded by Adam Garner in 2010 and is headquartered in Daresbury, the United Kingdom.

Part of Boldwood Ltd., Alan Bailey (Studios) Ltd. is a British company that provides public relations services. The company is based in London, UK. Alan Bailey (Studios was acquired by Hansard Group Ltd. on October 28, 2002.

Autoclenz Group Ltd. provides business support services. The company is headquartered in Swadlincote, the United Kingdom.

Boldwood Ltd. invests in companies that have a stake in public relations services. The private company is based in London, UK.

Part of Boldwood Ltd., Hansard Corporate Ltd. is a British company that provides public relations services. The company is based in London, UK.

Autoclenz Ltd. provides outsourced car valeting and vehicle preparation services. Its services include valeting, cosmetic repairs, customer experience, delivery and collection, imaging, premises cleaning and prestige valeting. The company was founded in 1969 and is headquartered in Swadlincote, the United Kingdom.

Autoclenz Holdings Ltd. is based in Swadlincote, UK, and has subsidiaries in the UK. Autoclenz Holdings Ltd. operates as a holding British company whose subsidiaries provide motor vehicle cleaning services. Autoclenz Holdings is a holding company founded in 2015.

Jupiter Diagnostics Holding Co. Ltd. operates as a holding company. The company was founded by Christopher Mark Balls on April 14, 2016 and is headquartered in London, the United Kingdom.

Penrhos Bio Ltd. is a British bioscience company that specializes in controlling the formation of harmful biofilms. The company is based in London, UK. The company has developed a novel and sustainable solution to biofilms by learning from the natural biology of the oceans. Penrhos Bio is working with potential license partners across a range of industries to develop lactam solutions to sector-specific biofilm challenges. The company was founded in 2019. Richard Andrew Hammond has been the CEO of the company since 2022.

Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom.

NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom.